MDL | - |
---|---|
Molecular Weight | 450.52 |
Molecular Formula | C27H30O6 |
SMILES | O=C1C(C2=CC=C(OC/C=C(C)/C)C(OC/C=C(C)/C)=C2)=COC3=CC(OC)=CC(OC)=C13 |
Glabrescione B is the first compound that binds the Hedgehog (Hh) modulator Gli1 . Glabrescione B impairs its activity by interfering with Gli1-DNA interaction. Glabrescione B inhibits the growth of Hedgehog-dependent tumor cells, the self-renewal ability, and clonogenicity of tumor-derived stem cells [1] [2] .
Gli1-DNA Interaction [1]
Glabrescione B (5 μM; 24-72 hours) inhibits the growth of Gli-dependent basal cell carcinoma
[2]
.
Glabrescione B (1-10 μM; 24-48 hours) decreases Gli1 mRNA expression levels
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay [1]
Cell Line: | ASZ001 BCC cells |
Concentration: | 5 μM |
Incubation Time: | 24-72 hours |
Result: | Basal cell carcinoma cell proliferation was impaired. |
Western Blot Analysis [1]
Cell Line: | ASZ001 BCC cells |
Concentration: | 1-10 μM |
Incubation Time: | 24-48 hours |
Result: | Gli1 mRNA expression levels was decreased. |
Animal Model: | Female NOD/SCID mice (ASZ001 BCC allografts) [2] |
Dosage: | 100 μmol/kg |
Administration: | I.p.; every second day for 18 days |
Result: | A significant reduction of tumor growth as well as Gli1 mRNA levels was observed. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 100 mg/mL ( 221.97 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.2197 mL | 11.0983 mL | 22.1966 mL |
5 mM | 0.4439 mL | 2.2197 mL | 4.4393 mL |
10 mM | 0.2220 mL | 1.1098 mL | 2.2197 mL |